Molecular imaging of apoptosis in cardiovascular diseases;Molekulare bildgebung der apoptose bei kardiovaskulären erkrankungen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 8, 2007, Pages 780-789

  Böhm, Ingrid ^a   Heverhagen, J T ^b   Behe, M ^b   Greschus, S ^a   Willinek, W ^a   Lohmaier, S ^a   Wilhelm, K ^a   Block, W ^a   Traber F ^a   Schild, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cardiac; Molecular imaging; Vascular

Indexed keywords

LIPOCORTIN 5; TECHNETIUM 99M;

ANGIOPLASTY; APOPTOSIS; CARDIOVASCULAR DISEASE; DIAGNOSTIC PROCEDURE; EXPERIMENTAL STUDY; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; IMPLANTATION; IN VIVO STUDY; MEDICAL RESEARCH; MICROENVIRONMENT; MOLECULAR IMAGING; MORBIDITY; MORTALITY; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; HUMANS; MOLECULAR PROBE TECHNIQUES;

EID: 34547891513     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963295     Document Type: Review

References (59)

1. Grimm J, Wunder A. Molekulare Bildgebung: Stand der Forschung. Fortschr Röntgenstr 2005; 177: 326-337
2. Ittrich H, Lange C, Dahnke H et al. Untersuchungen zur Markierung von mesenchymalen Stammzellen mit unterschiedlichen superparamagnetischen Eisenoxidpartikeln und Nachweisbarkeit in der MRT bei 3T. Fortschr Röntgenstr 2005; 177: 1151-1163
3. Kettering M, Winter J, Zeisberger M et al. Magnetisch basierte Steigerung der Nanopartikelaufnahme in Tumorzellen: Kombination von magnetisch induzierter Zellmarkierung und magnetischer Wärmebehandlung. Fortschr Röntgenstr 2006; 178: 1255-1260
4. Böhm I, Träber F, Block W et al. Molekulare Bildgebung von Apoptose und Nekrose - Biologische Grundlagen und Einsatz in der Onkologie. Fortschr Röntgenstr 2006; 178: 263-271
5. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 971-988
6. Deguchi JO, Aikawa M, Tung CH et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006; 114: 55-62
7. Chen J, Tung CH, Mahmood U et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105: 2766-2771
8. Haberkorn U, Kinscherf R, Krammer PH et al. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O- methyl)-fluoromethyl ketone. Nucl Med Biol 2001; 28: 793-798
9. Kopka K, Faust A, Keul P et al. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis. J Med Chem 2006; 49: 6704-6715
10. Messerli SM, Prabhakar S, Tang Y et al. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 2004; 6: 95-105
11. Bauer C, Bauder-Wuest U, Mier W et al. 131I-labeled peptides as caspase substrates for apoptosis imaging. J Nucl Med 2005; 46: 1066-1074
12. Mahnken AH, Günther RW, Krombach G. Kontrastangehobene MRT und MSCT zur kardialen Vitalitätsdiagnostik. Fortschr Röntgenstr 2006; 178: 771-780
13. Elsässer A, Vogt AM, Nef H et al. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol 2004; 43: 2191-2199
14. Böhm I, Schild H. Apoptosis: the complex scenario for a silent cell death. Molecular Imaging and Biology 2003; 5: 2-14
15. Vahlhaus C, Schäfers M, Bruns HJ et al. Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET Ann Noninvasive Electrocardiol 2002; 7: 349-356
16. Thimister PW, Hofstra I, Liem IH et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 2003; 44: 391-396
17. Taki J, Higuchi T, Kawashima A et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99 mTc-labeled annexin V. J Nucl Med 2004; 45: 1536-1541
18. Sosnovik DE, Schellenberger EA, Nahrendorf M et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005; 54: 718-724
19. Dumont EA, Reutelingsperger CPM, Smits JFM et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 2001; 7: 1352-1355
20. Persigehl T, Heindel W, Bremer C. MR and optical approaches to molecular imaging. Abdom Imaging 2005; 30: 342-354
21. Soubret A, Ntziachristos V. Fluorescence molecular tomography in the presence of background fluorescence. Phys Med Biol 2006; 51: 3983-4001
22. John AS, Dreyfus GD, Pennell DJ. Images in cardiovascular medicine. Reversible wall thinning in hibernation predicted by cardiovascular magnetic resonance. Circulation 2005; 111: e24-5
23. Ni Y, Pislaru C, Bosmans H et al. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radiol 2001; 11: 876-883
24. Pislaru SV, Ni Y, Pislaru C et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999; 99: 690-696
25. Schellenberger EA, Bogdanov Jr A, Högemann D et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging 2002; 1: 102-107
26. Schellenberger EA, Sosnovik D, Weissleder R et al. Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 2004; 15: 1062-1067
27. van Tilborg GA, Mulder WJ, Chin PT et al. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem 2006; 17: 865-868
28. Hiller KH, Waller C, Nahrendorf M et al. Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging 2006; 5: 115-121
29. Heverhagen JT, Graser A, Fahr A et al. Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability. Magn Reson Imaging 2004; 22: 483-487
30. Mangin M, Mahrholdt H, Sechtem U. Diagnostik der Myokarditis: Darstellung und Bewertung der verfügbaren Methoden. Dtsch Med Wochenschr 2006; 131: 1228-1234
31. Kadalie CT. Stellenwert der MRT bei chronischer Myokarditis. Z Kardiol 2005; 94: IV/94-96
32. Tokita N, Hasegawa S, Maruyama K et al. 99 mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging 2003; 30: 232-238
33. Klug G, Trieb T, Schocke MF et al. Myocarditis diagnosed by magnetic resonance imaging. Wien Klin Wochenschr 2006; 118: 21
34. Allanore Y, Vignaux O, Arnaud L et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 2006; 65: 249-252
35. Sechtem U, Mahrholdt H, Hager S et al. New non-invasive approaches for the diagnosis of cardiomyopathy: magnetic resonance imaging. Ernst Schering Res Found Workshop 2006; 55: 261-285
36. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherosclerosis. Nat Reviews - Drug Dis 2004; 3: 913-925
37. Shah PK, Falk E, Badimon JJ et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-1569
38. Johnson JL, Baker AH, Oka K et al. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 2006; 113: 2435-2444
39. Kolodgie FD, Petrov A, Virmani R et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003; 108: 3134-3139
40. Schäfers M, Riemann B, Kopka K et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004; 109: 2554-2559
41. Si-Tayeb K, Monvoisin A, Mazzocco C et al. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006; 169: 1390-1401
42. Odaka C, Tanioka M, Itoh T. Matrix metalloproteinase-9 in macrophages induces thymic neovascularization following thymocyte apoptosis. J Immunol 2005; 174: 846-853
43. Johnson LL, Schofield LM, Weber DK et al. Uptake of 111In-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation. J Nucl Med 2003; 45: 294-299
44. Dickson BC, Gotlieb AI. Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc Pathol 2003; 12: 237-248
45. Kietselaer BL, Reutelingsperger CP, Heidendal GA et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004; 350: 1472-1473
46. Laxman B, Hall DE, Bhojani MD et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 2002; 99: 16551-16555
47. Maintz D, Ozgun M, Hoffmeier A et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 2006; 27: 1732-1736
48. Schmitz SA. Eisenoxidverstärkte MRT inflammatorischeratherosklerotischer Läsionen: Ü bersichtexperimenteller und erster klinischer Ergebnisse. Fortschr Röntgenstr 2003; 175: 469-476
49. Cury RC, Houser SL, Furie KL et al. Vulnerable plaque detection by 3.0 tesla magnetic resonance imaging. Invest Radiol 2006; 41: 112-115
50. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol 2006; 59: 232-239
51. Skowasch D, Jabs A, Andrie R et al. Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis. J Vasc Res 2004; 41: 525-534
52. Beohar N, Flaherty JD, Davidson CJ et al. Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 2004; 109: 108-113
53. Johnson TW, Wu YX, Herdeg C et al. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler Thromb Vasc Biol 2005; 25: 754-759
54. Indolfi C, Mongiardo A, Spaccarotella C et al. The present and future of drug-eluting stents. Ital Heart J 2005; 6: 498-506
55. Nguyen KT, Shaikh N, Wawro D et al. Molecular responses of vascular smooth muscle cells to paclitaxel-eluting bioresorbable stent materials. J Biomed Mater Res A 2004; 69: 513-524
56. Curcio A, Torella D, Cuda G et al. Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis. Am J Physiol Circ Physiol 2004; 286: H902-H908
57. Venkatasubramanian RT, Grassl ED, Barocas VH et al. Effects of freezing and cryopreservation on the mechanical properties of arteries. Ann Biomed Eng 2006; 34: 823-832
58. Laird JR, Biamino G, McNamara T et al. Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results. J Endovasc Ther 2006; 13: II52-II59
59. Joye JD. The clinical application of cryoplasty for infrainguinal peripheral arterial disease. Tech Vasc Intery Radiol 2005; 8: 160-164